Mutations in HECW2 are associated with intellectual disability and epilepsy

Area of Science:

• Genetics
• Neuroscience
• Developmental Biology

Background:

• De novo mutations are a significant cause of neurodevelopmental disorders.
• Epilepsy and intellectual disability (ID) are often linked to genetic factors affecting brain development.

Purpose of the Study:

• To screen patients with epilepsy and intellectual disability for de novo mutations using exome sequencing.
• To identify known and novel causative mutations contributing to these conditions.

Main Methods:

• Exome sequencing was performed on 39 patient-parent trios.
• De novo mutations were identified and their clinical significance assessed using ACMG guidelines.
• Variants of unknown significance were analyzed in the context of prior neurodevelopmental disorder studies.

Main Results:

• Twenty-nine de novo mutations in coding sequences were identified across 39 trios.
• A molecular diagnosis was achieved in 11 families (28.2%) through analysis of de novo and inherited variants.
• HECW2 was implicated as a novel candidate gene for intellectual disability and epilepsy.

Conclusions:

• Exome sequencing is a valuable diagnostic tool for intellectual disability and epilepsy.
• The study confirms the critical role of de novo mutations in these disorders.
• HECW2 is highlighted as a new candidate gene for neurodevelopmental disorders, with network analysis aiding gene prioritization.